🔎 Trials Near Me

Home › Linfoma diffuso a grandi cellule B › Indiana

Studi clinici su Linfoma diffuso a grandi cellule B nello stato di Indiana

9 studi su Linfoma diffuso a grandi cellule B cercano partecipanti presso sedi nello stato di Indiana.

Città nello stato di Indiana

Testo ufficiale dello studio (inglese)

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

  • Northwest Cancer Center - Crown Point, Crown Point
  • Northwest Oncology LLC, Dyer
  • Saint Mary Medical Center, Hobart
  • e altri 4
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06649812

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
  • St Vincent Ascension at Peyton Manning Childrens Hospital, Indianapolis
  • Investigative Clinical Research of Indiana, Noblesville
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06091865

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

  • Fort Wayne Medical Oncology and Hematology ( Site 0149), Fort Wayne
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06717347

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

  • Fort Wayne Medical Oncology and Hematology, Fort Wayne
  • IU Simon Comprehensive Cancer Center, Indianapolis
  • Indiana Blood and Marrow Transplantation, Indianapolis
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 31 ago 2026 · NCT06500273

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • Indiana Blood and Marrow Transplantation, Indianapolis
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 ago 2026 · NCT05826535

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 10 lug 2026 · NCT05852717

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

  • Northwest Cancer Center - Main Campus, Crown Point
  • Northwest Oncology LLC, Dyer
  • Northwest Cancer Center - Hobart, Hobart
  • e altri 5
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 20 ott 2025 · NCT05890352

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

  • Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 7 apr 2023 · NCT04920617

Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL

  • Goshen Center for Cancer Care, Goshen
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 4 ago 2022 · NCT04502394

Fonte: ClinicalTrials.gov, dati recuperati il 2 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.